Compare McKesson Corporation (MCK) vs Snap Inc (SNAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Snap Inc — how do they compare? McKesson Corporation trades at $938.84 (market cap $108.46B), while Snap Inc trades at $6.24 (market cap $9.83B). The key difference: McKesson Corporation is far larger — about 11× Snap Inc's market cap, and McKesson Corporation pays a 0.4% dividend while Snap Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold McKesson Corporation for 74 Days and Snap Inc for 68 Days on average.
| MCK | SNAP | |
|---|---|---|
Market Cap | $108.46B | $9.83B |
Volume | 712,607 | 28,532,342 |
Sector | Health | Media |
52-Week High | $995.69 | $9.09 |
52-Week Low | $725.17 | $3.93 |
Typical Hold Time | 74 Days | 68 Days |
Enterprise Value | $115.00B | $11.39B |
Dividend Yield | 0.4% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $930.25, up 2.19% with strong technical momentum and bullish analyst sentiment. The stock shows consistent earnings beats with Q2 2026 EPS of $9.93 exceeding expectations of $9.56. Recent news highlights the extension of McKesson's pharmaceutical distribution agreement with CVS Health through 2032, reinforcing long-term revenue visibility. Revenue growth remains robust, climbing from $264.0B in 2022 to $359.1B in 2025, though net margins are thin at 1.12%.
McKesson presents a favorable risk-reward profile with 81% analyst buy ratings and a $956.43 consensus price target offering 2.8% upside. Key risks include margin pressure from drug pricing dynamics and policy uncertainty. The company's strong cash flow generation ($6.1B operating cash flow in 2025) and strategic focus on oncology and specialty distribution support continued growth, though investors should monitor debt levels and competitive pressures in healthcare distribution.
Snap stock trades at $5.865, up 0.95% on the day, with a bullish technical signal from moving averages. Revenue grew to $5.93 billion in 2025, and net losses narrowed to -$460 million, showing improving profitability. Recent news highlights the launch of SPECS Intelligence AI and enterprise partnerships with NVIDIA and Salesforce, driving positive sentiment. The consensus price target is $7.78, with 38% of analysts rating it a Buy.
The outlook remains cautious but improving, as revenue growth and narrowing losses present opportunity, but persistent net losses and high debt pose risks. Regulatory pressures and intense social media competition are key challenges. Analyst consensus leans Hold, reflecting a wait-and-see approach amid ongoing transformation efforts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Snap Inc
Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.
Read more on SNAP →
